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Bruce V. Thomsen,1 David A. Schneider, Katherine I. O’Rourke, Thomas Gidlewski,
James McLane, Robert W. Allen, Alex A. McIsaac, Gordon B. Mitchell, Delwyn P. Keane,
Terry R. Spraker, Aru Balachandran
Abstract. An effective live animal diagnostic test is needed to assist in the control of chronic wasting disease (CWD),
which has spread through captive and wild herds of white-tailed deer (Odocoileus virginianus) in Canada and the United
States. In the present study, the diagnostic accuracy of rectal mucosa biopsy sample testing was determined in white-tailed
deer from 4 CWD-infected captive herds. Specifically, the current study compared the immunohistochemical detection of
disease-associated prion protein in postmortem rectal mucosa biopsy samples to the CWD status of each deer as determined
by immunodiagnostic evaluations of the brainstem at the obex, the medial retropharyngeal lymph node, and the palatine tonsil.
The effects of age, sex, genotype, and disease progression were also evaluated. Diagnostic sensitivity on rectal biopsy samples
for CWD in white-tailed deer ranged from 63% to 100%; the pooled estimate of sensitivity was 68% with 95% confidence
limits (95% CLs) of 49% and 82%. However, diagnostic sensitivity was dependent on genotype at prion protein gene (PRNP)
codon 96 and on disease progression as assessed by obex grade. Diagnostic sensitivity was 76% (95% CLs: 49%, 91%) for
96GG deer but only 42% (95% CLs: 13%, 79%) for 96GS deer. Furthermore, diagnostic sensitivity was only 36% for deer
in the earliest stage of disease (obex grade 0) but was 100% for deer in the last 2 stages of preclinical disease (obex grades 3
and 4). The overall diagnostic specificity was 99.8%. Selective use of antemortem rectal biopsy sample testing would provide
valuable information during disease investigations of CWD-suspect deer herds.
Key words: Chronic wasting disease; rectal mucosa biopsy; white-tailed deer.

Introduction
Chronic wasting disease (CWD) is a transmissible spongiform encephalopathy of cervid species with naturally occurring infections identified in Canada and the United States
in white-tailed deer (Odocoileus virginianus), mule deer
(Odocoileus hemionus), Rocky Mountain elk (Cervus elaphus
nelsoni), and moose (Alces alces shirasi).1,18,19 Like other
transmissible spongiform encephalopathies, CWD has a long
incubation period lasting months to years, eventually leading
to the accumulation of abnormal protease resistant prion protein (PrPCWD) in the brain, resulting in neurologic disease and
death.18
Chronic wasting disease was first identified in Colorado
and has since been found in both domestic and wild cervids
in expanding regions of North America.18,19 Chronic wasting
disease has been identified in the provinces of Saskatchewan
and Alberta in Canada and in 19 states across the United

States (http://www.nwhc.usgs.gov/disease_information/chronic
_wasting_disease/). Control of the disease has been hampered
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by the lack of a highly sensitive and specific antemortem
diagnostic test method.13 Current methods in Canada and the
United States utilize brain stem, medial retropharyngeal
lymph node, and palatine tonsil samples collected postmortem, which are then tested by immunohistochemistry (IHC),
enzyme-linked immunosorbent assay (ELISA), and/or
Western blot (WB) to detect PrPCWD. In white-tailed deer,
PrPCWD accumulates within multiple lymphoid tissues such
as lymph nodes, tonsil, and gut-associated lymphoid tissue
during the subclinical phase of disease, prior to the accumulation of PrPCWD within the brain.7,8 Protease-resistant prion
protein in white-tailed deer has a similar tissue distribution
to scrapie within sheep and goats, and this wide tissue distribution of abnormal prion protein has been exploited by the
utilization of antemortem rectal biopsy testing for the control
and eradication of scrapie in Canada since 2006 and in the
United States since 2008.3–5 Scrapie diagnostic testing on
rectal biopsy samples by the U.S. Department of Agriculture
(USDA) is used in specific types of epidemiologic investigations and has been found to be a safe and effective method in
live animals.3 In white-tailed deer, biopsy samples from palatine tonsil and rectal mucosa have both shown promise as
possible antemortem methods to detect CWD.7,17,20 The rectal biopsy procedure has the advantages of being a simpler
and more rapid procedure that can often be performed without sedation.7
The purpose of the current study was to determine the
CWD diagnostic accuracy of immunohistochemical detection of PrPCWD in rectal biopsy samples of white-tailed deer
from known positive herds. Through a cooperative effort
between the Canadian Food Inspection Agency (CFIA) and
the USDA, rectal biopsy and other tissue samples were collected from white-tailed deer in 4 herds, each herd depopulated because of a previous diagnosis of CWD. All tissue
samples were collected postmortem. Detection of PrPCWD in
rectal biopsy samples was compared to the CWD infection
status of each animal as determined by the official test methods of each country utilizing samples of the brainstem, retropharyngeal lymph node, and tonsil. All rectal biopsy samples
were tested by IHC at a single laboratory. In addition, the
effect of age, sex, genotype at prion protein gene (PRNP)
codon 96, and stage of disease progression on the diagnostic
accuracy of rectal mucosa biopsy testing was examined.

Materials and methods
Study populations
The white-tailed deer captive herds in the present study
included 3 herds in Canada (Canada herds 1–3) and 1 herd in
the United States (U.S. herd 1). For the purposes of the
investigation, the study populations consisted of the deer
euthanized during depopulation of each farm. At the time of
depopulation, clinical signs of CWD were not evident in
any deer from these herds. Canada herd 1 was a 65-hectare
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breeding operation established in northeastern Saskatchewan
during the spring of 2005. Chronic wasting disease was first
diagnosed in 2 deer that were found dead in September 2007
and tested as part of a mandatory CWD surveillance program. There were 122 adult deer and fawns tested for CWD
in the facility at the time of depopulation in December 2007.
Canada herd 2 was a 57-hectare breeding and hunting operation located in northwestern Saskatchewan. Chronic wasting
disease was first diagnosed in 3 does that were slaughtered
and then tested as part of a mandatory CWD surveillance
program in January 2008. There were 385 deer (excluding
deer < 12 months of age, which are not routinely tested for
CWD as part of CFIA depopulation protocols) depopulated
and tested for CWD at the facility in May 2008. Canada
herd 3 was a 16-hectare breeding operation in northeastern
Saskatchewan. Epidemiologic investigations had determined
that this herd was the herd of origin of 2, previously identified, CWD-infected deer. The herd was confirmed to be infected
in January 2011, and 48 deer (excluding deer < 12 months of
age) were depopulated and tested for CWD in February
2011. U.S. herd 1 was a 72-hectare hunting operation in
Wisconsin in which CWD was first diagnosed on the farm in
an adult doe in the fall of 2008 as part of a voluntary CWD
surveillance program. In the winter of 2008, at the time of
the study and herd depopulation, the herd was composed of
66 adult deer and fawns.

Sample collection
After euthanasia, the sex and age of each deer was determined. The age of the deer was determined either by herd
records or was estimated by visual inspection of the teeth.
Brainstem at the obex, medial retropharyngeal lymph node,
and/or tonsil and rectal mucosa biopsy samples were collected for CWD testing. More specifically, an approximately
round, 2 cm in diameter portion of rectal mucosa immediately cranial to the anal mucocutaneous junction was sampled and then placed mucosal side down, within a
sponge-lined histology cassette.

Testing of rectal biopsy samples
Testing of the formalin-fixed rectal mucosa biopsy samples
from all 4 herds was performed at the USDA National
Veterinary Services Laboratories (Ames, Iowa) following a
previously described procedure.3 Briefly, after routine tissue
processing, the biopsy samples were embedded in paraffin
(with the mucosal surface facing, and parallel to, the front surface of the block). A 5-μm section was obtained at a depth of
approximately 250 μm and a second section at a depth of
approximately 350 μm from the surface of the mucosa.
Immunohistochemical testing was performed following the
USDA CWD test protocol with an automated immunostainera
using the mouse monoclonal 99/97.6.1 anti–prion protein
antibodyb as the primary antibody.14 Positive control tissues,
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commercial test kits according to the manufacturer’s instructions and as previously described.2,6 The ELISA absorbance
cut-off value for PrPCWD detection was calculated by adding
a fixed value of 0.09 to the mean optical density of the negative controls.6 The WB protein bands were evaluated using a
digital imaging system and analysis software.f

Grading of obex samples as an
estimate of disease progression

Figure 1. Rectal mucosa; white-tailed deer (Odocoileus virginianus). A prominent lymphoid follicle in the lamina propria contains abundant immunohistochemical staining for protease resistant
prion protein (PrPCWD). Streptavidin–alkaline phosphatase immunohistochemistry using an anti-prion antibody and hematoxylin
counterstain. Bar = 100 µm.

consisting of scrapie-positive brain and lymph node, were
included with each staining run. Tissues were considered positive if there was immunohistochemical staining of the appropriate character and location in the tissue (Fig. 1).3,18 Tissues
were considered negative if immunohistochemical staining of
the appropriate character and location in the tissue was not
detected in the tissue. Any lymphoid tissue samples, including
rectal biopsy samples that contained less than 6 lymph follicles in the entire sample, were considered inadequate to make
a negative test result determination. No minimum number of
lymphoid follicles was required to make a positive determination. Pathologists interpreting the rectal biopsy samples were
blinded to test results from other tissues.

Testing of obex, lymph node, and tonsil samples
Obex, lymph node, and palatine tonsil samples from U.S.
herd 1 were tested by the immunohistochemical procedure as
described previously for the rectal biopsy samples. Testing
of the obex, lymph node, and palatine tonsil samples from
Canada herds 1–3 was carried out by IHC, ELISA, and/or
WB and included positive and negative controls on each
assay. All 3 methods were applied to obex, lymph node, and
palatine tonsil samples from Canada herd 1. At the time of
testing samples, from Canada herds 2 and 3, the ELISA
method was being used to first screen all 3 tissues, after
which a concordant IHC or WB result was used to confirm
all positive samples. The methods have been previously
described for IHC using a mouse monoclonal 99/97.6.1 anti–
prion protein antibodyc as the primary antibody with an automated immunostainer.a,2,14 Immunodetection by ELISAd
and WBe was performed on unfixed tissue samples using

Chronic wasting disease progression was estimated using
IHC in each deer that was positive on brain tissue by each
country’s initial screening test (ELISA testing for Canada
herds 1–3) and IHC testing for U.S. herd 1. Obex grading
was performed similarly to previously described methods.12
Obex grades were assigned based on the following criteria:
grade 0, no IHC PrPCWD staining present in the obex or
ELISA negative on fresh obex samples; grade 1, minimal
IHC PrPCWD staining primarily restricted to the ventral area
of the dorsal motor nucleus of the vagus (DMNV); grade 2,
moderate IHC PrPCWD staining in the DMNV and the nucleus
of the solitary tract; grade 3, heavy IHC PrPCWD staining
present in the DMNV with lighter staining that extended to
other adjacent nuclei (including the nucleus of the solitary
tract) and white matter; grade 4, IHC PrPCWD staining present in the DMNV, adjacent nuclei, and white matter.

Determination of codon 96 polymorphism
Two methods were used for the determination of the codon
96 polymorphism. For Canada herds 1 and 2 and U.S. herd 1,
DNA was extracted from archived fixed or frozen tissue. The
open reading frame of the PRNP gene was amplified and
sequenced as described using primers specific for the cervid
functional gene and excluding amplification of the cervid
processed pseudogene.10 For Canada herd 3, genomic DNA
samples were isolated and purified from the ethylenediamine
tetra-acetic acid–anticoagulated blood or homogenized
brain tissue using an automated DNA extractor. Real-time
polymerase chain reaction (PCR) assays were performed
using primers (5’-AGCCACATGGTGGTGGAG-3’; 5’-TG
GTTTACTGGGCTTGTTCC-3’) and allelic-specific probes
(FAM-TCAAGGTGGTACCCAC–MGBNFQ; VIC-TCAA
AGTGGTACCCACAG–MGBNFQ).g,h The genotype was
determined based on the baseline threshold and threshold
cycle (Ct) generated by detection software and using positive
control samples to discriminate the GG, GS, and SS alleles.

Statistical methods
Data sets were recorded in spreadsheetsi and imported into
SASj for data handling, summary and analyses, and graph
production. Within each herd, one-way table analysis (the
Frequency procedure, SAS) was used to compute the exact
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binomial and 95% confidence intervals of intraherd prevalence
of CWD. Stepwise selection and exact conditional logistic
analyses (the Logistic procedure, SAS) were used to determine the effects of deer factors (age, sex, and PRNP codon
96) on the probability of a positive CWD infection status.
The model used reference cell coding and lenient P values
for model entry (0.5) and elimination (0.1). Exact odds ratios
with 95% upper and lower confidence limits (95% CLs) conditioned by all significant explanatory factors were subsequently determined. Association between disease progression
(estimated by obex grade) and PRNP genotype at codon
96 was determined by requesting Somers D statistics (the
Frequency procedure, SAS) for all study herd deer with a
positive CWD infection status and complete data set.
The diagnostic accuracy (sensitivity and specificity) for
determining CWD infection status of white-tailed deer by
rectal biopsy testing was determined per herd using the
Frequency procedure (SAS) as implemented in SAS Usage
Note 24170 (http://support.sas.com/kb/24/170.html). The
Surveyselect procedure (SAS) was used to randomly select 1
diagnostic result per deer in Canada herds 2 and 3 in which 2
diagnostic rectal mucosa biopsy samples had been collected
but assigned discordant outcomes. Random selections were
made within herd strata defined by disease status, age group,
and codon 96 in order to avoid inadvertent introduction of
selection bias. A meta-analytic bivariate approach was used
to compute pooled estimates of diagnostic sensitivity and
specificity.11 The generalized linear random-effects model
(random subject effect, herd ID; the GLIMMIX procedure,
SAS) was based on code provided previously.9 The metaanalytic pooled estimates were first computed using only the
herds of the current study (n = 4) and then inclusive of data
from 2 additional herds (n = 6 total) from a similarly conducted U.S. study.7 Unless otherwise stated, all meta-analyses converged with satisfaction of the convergence
criterion.

Results
Case herds summary statistics
Deer herd populations, PRNP genotype at codon 96, sex,
age, and CWD infection status are summarized in Table 1.
Canada herd 1 was composed of 122 deer, which were
depopulated in December 2007, 38 (31%) of which were
determined to be CWD positive by testing of obex, lymph
node, and/or palatine tonsil samples. Eleven (9%) of these
deer had rectal biopsy samples with an insufficient number
of lymphoid follicles and were excluded from the rectal
biopsy statistical analyses. Canada herd 2 contained 385 deer
when the facility was depopulated in May 2008, 79 (21%) of
which were determined to be CWD positive based on testing
of obex, lymph node, or palatine tonsil. Forty-seven (12%)
of these deer had rectal biopsy samples with an insufficient
number of lymphoid follicles and were excluded from the
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rectal biopsy statistical analyses. Deer from the breeding
facility ranged from 1 to 12 years of age, but for 210 (55%)
of these deer, age was recorded only as “M” for mature
(4–8 years old) and were thus excluded from further analyses
that included age as a continuous covariate. Thirty-two
(67%) of the 48 deer in Canada herd 3 at the time of depopulation were determined to be CWD positive. Twenty-one
(44%) of these deer had rectal biopsy samples with an insufficient number of lymphoid follicles and were excluded from
the rectal biopsy statistical analyses. U.S. herd 1 contained
66 deer at the time of depopulation of which only a single
deer (approximately 2%) was determined to be CWD positive. Eleven (17%) of these deer had rectal biopsy samples
with an insufficient number of lymphoid follicles and were
excluded from the rectal biopsy statistical analyses.

Effects of age, sex, and genotype at PRNP codon 96
on likelihood of a positive CWD infection status
The potential influence of age, sex, and genotype at PRNP
codon 96 on the likelihood of a positive CWD infection status at the time of depopulation was investigated. Having
only 1 positive case, U.S. herd 1was excluded from this analysis. A significant dependence on age or sex at the time of
depopulation was not detected for deer in any of the Canadian
herds. A positive CWD infection status was significantly
dependent on codon 96 for deer from Canada herds 1 and 3
but this factor did not reach statistical significance for deer
from Canada herd 2 (Table 2). From the exact conditional
logistic analysis, odds ratios relative to 96GG deer were significant for both 96GS deer and 96SS deer such that 96GS
deer were overall approximately 3 times less likely, and
96SS deer approximately 19 times less likely, than 96GG
deer to be CWD positive at the time of depopulation.

Diagnostic accuracy of postmortem
rectal biopsy testing
The diagnostic sensitivity of postmortem rectal biopsy testing for determination of CWD infection status is summarized in Figure 2 as a forest plot accompanied by summary
data for each herd. The diagnostic sensitivity for individual
herd investigations varied from 63% to 100%. The pooled
estimate of diagnostic sensitivity (Fig. 2) for the herds
of this study (n = 4 herds) was 68% with 95% CLs of 49%
and 82%.
Regarding diagnostic specificity of postmortem rectal
biopsy sample testing for determination of CWD infection
status in white-tailed deer, only 1 sample was scored as positive in an animal in which PrPCWD was not detected (in this
context referred to as a “false-positive”; Fig. 2). Thus, estimates of diagnostic specificity under these conditions ranged
from 99.6% in Canada herd 2 to 100% in all other study
herds. The pooled estimate of specificity was 99.8% (n = 4
herds, 95% CLs: 84.1%, 100.0%). Given the near uniform
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Table 1. White-tailed deer (Odocoileus virginianus) herd characteristics for chronic wasting disease (CWD) prevalence with 95%
confidence limits (95% CLs), PRNP genotype at codon 96, sex, and age.

Study
population

Total no. of
deer

Canadian herd 1

122

CWD prevalence*
(95% CL)†
31.15 (23.07, 40.16)

PRNP at codon 96‡
[frequency]
GG [84 (68.85%)]

Age (years) by CWD infection status¦
(min.–[median]–max.) [frequency]
Sex§ [frequency]
F [42 (34.43%)]
M [41 (33.61%)]

CWD+

CWD–

0.58–[1.58]–5.58
[19 (15.57%)]
0.58–[2.08]–3.58
[14 (11.48%)]

0.50–[1.58]–4.58
[23 (18.85%)]
0.5–[1.58]–7.58
[27 (22.13%)]
2.58
[1 (0.82%)]
0.58–[2.08]–7.58
[18 (14.75)]
0.58–[2.58]–4.58
[13 (10.66%)]
1.58–1.58
[2 (1.64%)]
[142 (36.88%)]
[129 (33.51%)]
[10 (2.60%)]
[6 (1.56%)]
[6 (1.56%)]
[13 (3.38%)]
3
[1 (2.08%)]

Na [1 (0.82%)]
GS [36 (29.51%)]

F [21 (17.21%)]
M [15 (12.30%)]

Canadian herd 2

385

20.52 (16.60, 24.90)

NA [2 (1.64%)]

F [2 (1.64%)]

GG [347 (90.13%)]

F [175 (45.45%)]
M [172 (44.68%)]
F [10 (2.60%)]
M [9 (2.34%)]
F [6 (1.56%)]
M [13 (3.38%)]
F [9 (18.75%)]

GS [19 (4.94%)]
NA [19 (4.94%)]
Canadian herd 3

48

66.67 (51.59, 79.60)

GG [10 (20.83%)]

M [1 (2.08%)]

U.S. herd 1

66

1.52 (0.04, 8.16)

GS [30 (62.50%)]

F [30 (62.50%)]

SS [8 (16.67%)]

F [8 (16.67%)]

GG [49 (74.24%)]
GS [17 (25.76%)]

F [26 (39.39%)]
M [23 (34.85%)]
F [12 (18.18%)]
M [5 (7.58%)]

0.50–[2.58]–2.58
[3 (2.46%)]
4.58–7.58
[2 (1.64%)]

[33 (8.57%)]
[43 (11.17%)]
[3 (0.78%)]

2–[4]–9
[8 (16.67%)]
4
[1 (2.08%)]
2–[4]–11
[21 (43.75%)#]
6–9
[2 (4.17%)]
[1 (1.52%)]

3–[7]–11
[9 (18.75%)]
2–[3]–5
[6 (12.50%)]
[25 (37.88%)]
[23 (34.85%)]
[12 (18.18%)]
[5 (7.58%)]

* The intraherd binomial proportion expressed here as the percentage positive.
† Exact 95% confidence limits (95% CLs) for the intraherd binomial proportion of CWD status = positive.
‡ PRNP codon 96 genotype given as the deduced amino acids: G = glycine; S = serine; NA = information not available.
§ F = female; M = male.
¦ Detection of PrPCWD by immunoassay: + = positive; – = negative.
# Includes 2 animals with missing age data; median based on 19 animals.

Table 2. Effect of genotype at PRNP codon 96 on the
likelihood of a positive chronic wasting disease infection status in
Canada herds of white-tailed deer.*
Population
Canada herd 1
Canada herd 2
Canada herd 3
Overall estimates

Exact odds ratios
(vs. 96GG)

LCL, UCL

P value

96GS: 0.252
96GS: 0.669
96GS: 0.267
96SS: 0.048
96GS: 0.338
96SS: 0.052

0.069, 0.746
0.122, 2.427
0.005, 2.476
<0.001, 0.688
0.137, 0.748
0.004, 0.402

0.0088
0.7663
0.4085
0.0181
0.0048
0.0021

* U.S. herd 1 was excluded from this analysis because the herd contained
only a single chronic wasting disease–positive deer. LCL, UCL = 95%
lower and upper confidence limits, respectively.

accuracy of postmortem rectal biopsy testing with regard to
diagnostic specificity, further investigations were limited to
testing for the effects of deer factors on rectal biopsy sample
diagnostic sensitivity.

Effects of age, sex, genotype at PRNP codon 96,
and stage of disease progression on diagnostic
sensitivity
Considering the significant effects of PRNP codon 96 polymorphism on the temporal patterns of PrPCWD detection in
rectal biopsy samples of deer and, in the present study, on the
likelihood of a positive CWD infection status, the effect
of genotype at codon 96 on rectal biopsy sample diagnostic
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Figure 2. Rectal biopsy sample diagnostic sensitivity for chronic wasting disease in preclinical North American white-tailed deer
(Odocoileus virginianus). A forest plot is shown to aid comparison of test sensitivities between herds (squares) and the pooled estimate
(diamond). To the right of each plot is given the exact measures of sensitivity (sens), lower and upper 95% confidence limits (LCL, UCL),
and the frequencies of rectal biopsy test results categorized relative to gold standard testing. TP = true-positive; FP = false-positive; FN =
false-negative; TN = true-negative.

Figure 3. Rectal biopsy sample diagnostic sensitivity for chronic wasting disease in preclinical North American white-tailed deer
(Odocoileus virginianus) characterized by PRNP codon 96 genotype. A forest plot is shown to aid comparison of test sensitivities between
herds (squares) and the pooled estimates (diamonds). To the right of each plot is given the exact measures of sensitivity (sens), lower and
upper 95% confidence limits (LCL, UCL), and the frequencies of rectal biopsy test results categorized relative to gold standard testing. TP =
true-positive; FP = false-positive; FN = false-negative; TN = true-negative.

sensitivity was examined.20 For individual herds, exact estimates of diagnostic sensitivities ranged from 67% to 100% in
96GG deer and from 0% to 60% in 96GS deer (Fig. 3). Only
8 96SS deer were identified in the current study, 2 of which
were determined to be CWD positive (Table 1). PrPCWD was
not detected in the rectal biopsy samples from either of the 2
CWD-positive 96SS deer. The pooled estimates of rectal

biopsy sample diagnostic sensitivity by genotype at codon 96
were 76% (95% CLs: 49%, 91%) for 96GG deer and 42%
(95% CLs: 13%, 79%) for 96GS deer; a pooled estimate for
96SS deer was not made given the number of cases.
All deer in the present study had unknown sources and
timing of exposure and were deemed to be nonclinical at
the time of depopulation. Thus, brainstem accumulation of
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Figure 4. Rectal biopsy sample diagnostic sensitivity for chronic wasting disease (CWD) in preclinical North American white-tailed
deer (Odocoileus virginianus) characterized by brainstem accumulation of protease resistant prion protein (PrPCWD) at the level of the obex
(obex grade). Obex grade (OG) ranged from 0 (PrPCWD not detected) to 4 (maximum accumulation). A forest plot is shown to aid comparison
of test sensitivities between herds (squares) and the pooled estimates (diamonds). To the right of each plot is given the exact measures of
sensitivity (sens), lower and upper 95% confidence limits (LCL, UCL), and the frequencies of rectal biopsy test results categorized relative
to gold standard testing. TP = true-positive; FP = false-positive; FN = false-negative; TN = true-negative).

PrPCWD at the level of the obex (obex grade, where 0 = not
detected and 4 = maximum accumulation) was used as a surrogate indicator of disease progression in CWD-positive
deer. As seen in Figure 4, there was a clear association of
early disease progression (low obex grades) with lower estimates of rectal biopsy sample diagnostic sensitivity. Given
smaller numbers of CWD-positive deer within each obex
grade subgroup, the measures of sensitivity were somewhat
variable between herds. Nevertheless, the modeled effect of

obex grade on rectal biopsy sample diagnostic sensitivity
was significant in the meta-analysis of the study herds
(P = 0.0230). The pooled estimates of sensitivity were 36%
for obex grade 0 deer, 83% for obex grade 1 deer, 93% for
obex grade 2 deer, and 100% for deer with obex grades 3 or 4.
To test the hypothesis that reduced rectal biopsy sample
diagnostic sensitivity in white-tailed deer with G96S polymorphism might be associated with slower disease progression, the association of obex grade with genotype at codon
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Figure 5. The proportional brainstem accumulation of protease resistant prion protein (PrPCWD) at the level of the obex (obex grade) in
North American white-tailed deer (Odocoileus virginianus) with preclinical chronic wasting disease (CWD) grouped by genotype at PRNP
codon 96. Note the decreased proportion of deer with G96S polymorphism that have grade 1 or greater accumulation of PrPCWD. Data
represent the pooled records of deer for which obex grades (scale: 0, PrPCWD not detected; 4, maximum accumulation) and genotypes were
available (Canada herds 1, 2, and 3 representing 119 GG, 29 GS, and 2 SS deer).

96 in deer with a positive CWD infection status at the time of
depopulation was measured. As shown in Figure 5, the proportion of deer in later stages of disease progression (obex
grades > 0) decreased with G96S polymorphism, though this
association did not reach statistical significance (Somers D =
–0.2066, 95% CLs: –0.4188, 0.0057; P = 0.0645). When
similarly stratified by stage of disease progression, G96S
polymorphism also appears to be negatively associated with
the proportion of positive lymph follicles per rectal biopsy
sample of CWD-positive white-tailed deer (Fig. 6).

Discussion
A safe and effective live animal diagnostic test is needed to
assist in the control of CWD, which currently relies on testing of samples collected only after the death of the deer.
Identification of CWD-infected herds is further hindered
because the disease has a long subclinical period.18 The current study included over 600 clinically normal white-tailed
deer, in 4 genetically and geographically diverse herds, and
showed that rectal biopsy sample testing was an effective
method in detecting subclinical CWD infection. The diagnostic sensitivity of rectal biopsy testing for determining
CWD infection status ranged from 63% to 100% in the 4
white-tailed deer herds in the study. The aim of the metaanalytic modeling in the present study was to improve the
estimate of diagnostic sensitivity accuracy in a manner more
broadly applicable to future application.9,11 Thus, the pooled
estimate of diagnostic test sensitivity of rectal biopsy testing
was 68% when based on the 4 herds of the current study,
which was refined to 74% (95% CLs: 60% and 85%) after
inclusion of data from 2 additional herds from a similarly
conducted study (data not shown).7 Conversely, false-negative results should be expected from rectal biopsy samples in
generally one-fourth of all CWD-infected deer. Thus, a negative test result based on a single rectal biopsy sample should
not be interpreted as a deer being free of CWD infection.

Figure 6. The proportion of protease resistant prion protein
(PrPCWD)-positive rectal mucosal lymphoid follicles in North
American white-tailed deer (Odocoileus virginianus) with preclinical
chronic wasting disease (CWD) and grouped by genotype at PRNP
codon 96 and disease progression. Disease progression estimated by
brainstem accumulation of PrPCWD at the level of the obex (obex grade:
0, PrPCWD not detected; 4, maximum accumulation). Shown are box
plots depicting the interquartile range (gray box with limits of 25th
and 75th percentiles), mean (diamond) and median (gray box center
line), and data falling within (stems) and outside (open circles) the 1.5
interquartile range. Data represent deer for which the proportion of
positive rectal mucosal lymphoid follicles could be determined and
for which obex grades and genotypes were available (Canada herds 1,
2, and 3 representing 196 GG, 35 GS, and 2 SS deer).
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Rectal biopsy diagnostic testing of deer should be done
concurrently with PRNP genotype testing in order to make a
more accurate assessment of test results. In an experimental
inoculation study of CWD in white-tail deer, PrPCWD was
detected at earlier time periods postinoculation in tonsil and
rectal mucosa in codon 96GG deer as compared to 96GS and
96SS deer.20 As demonstrated in the present study, knowledge of the genotype is important because rectal biopsy sample test sensitivity was 76% for 96GG deer, but dropped to
42% for 96GS deer. Additionally and not surprisingly, the
rectal biopsy test sensitivity was the greatest (100%) in deer
with advanced disease as evidenced by abundant PrPCWD in
the brain and the lowest (36%) in deer in which PrPCWD was
not detected in brain tissue and only detected in lymph tissues; thus in agreement with a previous study.7 Higher rates
of false-negative rectal biopsy results are expected in whitetailed deer in earlier stages of CWD disease progression and
in deer having PRNP G96S polymorphism.
The diagnostic specificity of rectal biopsy sample testing for
determining CWD infection status was 99.8% and not 100%
for the 4 herds of the current study due to a single deer in
Canada herd 2 classified as a false positive. The rectal biopsy
from the 2-year-old, codon 96GG deer had a single positive
lymphoid follicle out of 143 total follicles, and the positive
staining was repeatable on serial tissue sections. Possible explanations for these conflicting test results include ineffective subsampling of the obex and lymph node samples, which may
have had limited focal PrPCWD deposition and led to falsenegative obex and lymph node results. An abnormal PrPCWD
tissue distribution pattern due to individual animal variation is
another possibility. Other studies have identified deer in which
the PrPCWD tissue distribution did not follow the expected pattern of appearing in select lymph tissues before appearing in the
brainstem (e.g., a white-tailed deer in which PrPCWD was found
only within brain tissue and not within lymph node samples).8
The effect of genotype polymorphism at codon 96 was
also examined because it has been shown to correlate with
the CWD infection status of deer.8,10 Chronic wasting disease infection status based on brain, lymph node, and
palatine tonsil testing was negatively associated with polymorphisms of codon 96, such that deer with G96S polymorphism were less likely than GG deer to be test-positive at the
time of depopulation. Though this association with the heterozygous genotype (96GS) reached statistical significance
only in Canada herd 1, the estimated odds ratios for this
genotype in Canada herds 2 and 3 were of similar magnitude
and direction. However, the effect of serine at codon 96 does
not prevent CWD infection, as evidenced in the respective
70% and 25% infection rates in 96GS and 96SS deer of
Canada herd 3. Disease progression, as measured by obex
grading, also appeared to be slower in 96GS and 96SS deer
as compared to 96GG herd mates, a conclusion consistent
with previous findings.7,8,20 There may be other unidentified
polymorphisms of the prion gene that have additional influence on the pathogenesis of CWD.

Although the samples in the current study were collected
postmortem, rectal biopsy testing for CWD and scrapie on
live animals has been shown to be safe for the animal and
relatively simple to perform by the surgeon.3,15 When performing the rectal biopsy, care must be taken to identify the
proper biopsy site in order to obtain a sample that contains
lymphoid follicles. Lymphoid follicles are most abundant
within an approximately 1 cm–wide band of mucosa and
submucosa immediately cranial to the stratified squamous
epithelium of the rectoanal junction; samples collected proximal or distal to that location have fewer or no lymphoid
follicles, which results in nondiagnostic samples.7 Fewer
lymph follicles are also found within rectal biopsy samples
collected from older animals.3,16 In the present study, the percentage of samples with an insufficient number of follicles
occurred at an unexpectedly high rate (44%) in Canada herd
3, while the other 3 herds had rates of 9–17%, which is similar to a previous study.7 Because the procedure causes minimal discomfort to the animal, the procedure is often
performed using only restraint in proper animal handling
facilities and topical anesthesia.3,15 In contrast, the only other
commonly used live animal CWD test used in research is the
palatine tonsil biopsy.20 The palatine tonsil biopsy is a more
complex procedure that carries potentially greater risk due to
the necessity of sedation or general anesthesia, but has shown
a greater sensitivity at detecting PrPCWD in the early stages of
disease.7,20
The current study provides additional evidence that rectal
biopsy samples can be used successfully to detect subclinical
CWD infections in white-tailed deer. Polymorphisms of
codon 96 and stage of disease progression have major effects
on the expected level of diagnostic sensitivity, so any interpretation of biopsy sample results in which PrPCWD is not
detected should consider these 2 factors. Genotype testing
can easily identify the codon 96 polymorphism of each deer.
However, estimating the level of disease progression is much
more difficult and often impossible, but could potentially be
estimated based on the predicted date of exposure. One
potential use for this test may be for epidemiologic investigations of CWD-suspect deer herds. Selective use of this test
to investigate herds suspected of having subclinical CWD, in
conjunction with traditional postmortem testing, could provide valuable information to animal health officials as well
as reduce the costs associated with postmortem testing.
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